Brand & Product Security

. He can be reached at nsaraceno@mjhlifesciences.com.

Articles

The acquisition strengthens M&D’s specialty portfolio, broadens access to plasma-derived therapies, and supports phased integration focused on regulatory compliance.

Morris & Dickson Acquires Prodigy Health to Expand Specialty and Plasma Distribution Capabilities

Associate Editorial Director
Pharmaceutical Commerce

Even the threat of Greenland-related tariffs rattled drug supply chains and uncovered industry vulnerabilities to instability. 

Pharma Industry Uncertainty in Wake of On/Off Greenland Tariffs

Podcasts

In today’s Pharma Pulse, the United States finalizes its departure from global health oversight, while domestic providers face a record-breaking surge in respiratory hospitalizations.

Pharma Pulse: US Exits the World Health Organization; Hospitals Overwhelmed by Historic Flu Crisis

The agency will evaluate FISP after early results show major gains in speed, capacity, and real-time risk mitigation across US ports of entry.

FDA Reviews ImportShield Program as Processing Gains Boost Import Oversight and Supply Chain Protection

Videos

Artificial intelligence is helping pharma teams uncover critical safety signals faster, lower costs, and shift pharmacovigilance from compliance to competitive advantage.

The Future of Drug Safety

In today’s Pharma Pulse, Congress races to secure funding, while Novavax nets a half-billion-dollar validation of its non-aluminum vaccine technology.

Pharma Pulse: Federal Funding Averts Shutdown and Pfizer’s Adjuvant Play

In today’s Pharma Pulse, the FDA and EMA synchronize on AI standards, a potential divide in pricing strategy occurs, and BoomRx launches a needle-free nanoemulsion for weight loss.

Pharma Pulse: Global AI Alignment, the TrumpRx Pivot, and Nano-Delivery GLP-1s

The company brings its temperature-controlled Superbox to the US pharma industry, aiming to improve speed, compliance, and resilience in the cold chain process.

Dawsongroup tcs USA Launches in the States

In today’s Pharma Pulse, AbbVie joins TrumpRx, shingles vaccines reveal a longevity boost, and HER2 therapies break new ground in cancer treatment.

Pharma Pulse: Navigating the New Era of Healthcare

The company will participate in the Trump administration’s direct-to-patient drug platform, while committing $100 billion to US R&D and manufacturing.

Legal & Regulatory